Skip to main content
. 2016 Feb 26;7(14):18876–18886. doi: 10.18632/oncotarget.7739

Figure 1. Number of adenocarcinoma samples with genetic alteration classified by cell signaling pathway.

Figure 1

Genetic alterations from NGS reports were classified by cell signaling pathway, such as RAS/MAPK, RTK/GFs, PI3K/mTOR, p53, Wnt pathways, and cell cycling. The ordinate indicated number of adenocarcinoma samples with alterations. RTK/GFs: Receptor tyrosine kinase/Growth factors.